These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36969037)

  • 1. Prognostic value of β-Arrestins in combination with glucocorticoid receptor in epithelial ovarian cancer.
    Ryu JW; Shin HY; Kim HS; Han GH; Kim JW; Lee HN; Cho H; Chung JY; Kim JH
    Front Oncol; 2023; 13():1104521. PubMed ID: 36969037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of β-arrestins blocks glucocorticoid receptor and severely retards lung and liver development in mice.
    Zhang M; Teng H; Shi J; Zhang Y
    Mech Dev; 2011; 128(7-10):368-75. PubMed ID: 21824517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High glucocorticoid receptor expression predicts short progression-free survival in ovarian cancer.
    Veneris JT; Darcy KM; Mhawech-Fauceglia P; Tian C; Lengyel E; Lastra RR; Pejovic T; Conzen SD; Fleming GF
    Gynecol Oncol; 2017 Jul; 146(1):153-160. PubMed ID: 28456378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. β-arrestin 2 Is a Prognostic Factor for Survival of Ovarian Cancer Patients Upregulating Cell Proliferation.
    Czogalla B; Partenheimer A; Jeschke U; von Schönfeldt V; Mayr D; Mahner S; Burges A; Simoni M; Melli B; Benevelli R; Bertini S; Casarini L; Trillsch F
    Front Endocrinol (Lausanne); 2020; 11():554733. PubMed ID: 33042017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-arrestin links endothelin A receptor to beta-catenin signaling to induce ovarian cancer cell invasion and metastasis.
    Rosanò L; Cianfrocca R; Masi S; Spinella F; Di Castro V; Biroccio A; Salvati E; Nicotra MR; Natali PG; Bagnato A
    Proc Natl Acad Sci U S A; 2009 Feb; 106(8):2806-11. PubMed ID: 19202075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocorticoids regulate arrestin gene expression and redirect the signaling profile of G protein-coupled receptors.
    Oakley RH; Revollo J; Cidlowski JA
    Proc Natl Acad Sci U S A; 2012 Oct; 109(43):17591-6. PubMed ID: 23045642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β-Arrestin-1 inhibits glucocorticoid receptor turnover and alters glucocorticoid signaling.
    Petrillo MG; Oakley RH; Cidlowski JA
    J Biol Chem; 2019 Jul; 294(29):11225-11239. PubMed ID: 31167788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexamethasone in the presence of desipramine enhances MAPK/ERK1/2 signaling possibly via its interference with β-arrestin.
    Lucki A; Klein E; Karry R; Ben-Shachar D
    J Neural Transm (Vienna); 2014; 121(3):289-98. PubMed ID: 24132698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Region-specific glucocorticoid receptor promoter methylation has both positive and negative prognostic value in patients with estrogen receptor-positive breast cancer.
    Snider H; Villavarajan B; Peng Y; Shepherd LE; Robinson AC; Mueller CR
    Clin Epigenetics; 2019 Nov; 11(1):155. PubMed ID: 31675993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stromal expression of β-arrestin-1 predicts clinical outcome and tamoxifen response in breast cancer.
    Lundgren K; Tobin NP; Lehn S; Stål O; Rydén L; Jirström K; Landberg G
    J Mol Diagn; 2011 May; 13(3):340-51. PubMed ID: 21497294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. β-Arrestin 1 is required for endothelin-1-induced NF-κB activation in ovarian cancer cells.
    Cianfrocca R; Tocci P; Semprucci E; Spinella F; Di Castro V; Bagnato A; Rosanò L
    Life Sci; 2014 Nov; 118(2):179-84. PubMed ID: 24530737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoid receptor expression is associated with inferior overall survival independent of BRCA mutation status in ovarian cancer.
    Veneris JT; Huang L; Churpek JE; Conzen SD; Fleming GF
    Int J Gynecol Cancer; 2019 Feb; 29(2):357-364. PubMed ID: 30683758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
    Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
    Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A direct role for arrestins in desensitization of the luteinizing hormone/choriogonadotropin receptor in porcine ovarian follicular membranes.
    Mukherjee S; Palczewski K; Gurevich V; Benovic JL; Banga JP; Hunzicker-Dunn M
    Proc Natl Acad Sci U S A; 1999 Jan; 96(2):493-8. PubMed ID: 9892661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The clinical significance of β-arrestin 2 expression in the serum of non-small cell lung cancer patients].
    Wu Z; Tong W; Tan Z; Wang S; Lin P
    Zhongguo Fei Ai Za Zhi; 2011 Jun; 14(6):497-501. PubMed ID: 21645452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine receptor D4 internalization requires a beta-arrestin and a visual arrestin.
    Deming JD; Shin JA; Lim K; Lee EJ; Van Craenenbroeck K; Craft CM
    Cell Signal; 2015 Oct; 27(10):2002-13. PubMed ID: 26169958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoid Receptor and Ovarian Cancer: From Biology to Therapeutic Intervention.
    Buonaiuto R; Neola G; Cecere SC; Caltavituro A; Cefaliello A; Pietroluongo E; De Placido P; Giuliano M; Arpino G; De Angelis C
    Biomolecules; 2023 Apr; 13(4):. PubMed ID: 37189400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-Arrestin 1 and 2 and G protein-coupled receptor kinase 2 expression in pituitary adenomas: role in the regulation of response to somatostatin analogue treatment in patients with acromegaly.
    Gatto F; Feelders R; van der Pas R; Kros JM; Dogan F; van Koetsveld PM; van der Lelij AJ; Neggers SJ; Minuto F; de Herder W; Lamberts SW; Ferone D; Hofland LJ
    Endocrinology; 2013 Dec; 154(12):4715-25. PubMed ID: 24169548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low beta-arrestin expression correlates with the responsiveness to long-term somatostatin analog treatment in acromegaly.
    Gatto F; Biermasz NR; Feelders RA; Kros JM; Dogan F; van der Lely AJ; Neggers SJ; Lamberts SW; Pereira AM; Ferone D; Hofland LJ
    Eur J Endocrinol; 2016 May; 174(5):651-62. PubMed ID: 26888629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of glucocorticoid receptor in prostate cancer and its clinical significance].
    Guo YS; Wang WB; Zhang SD; Zhang MQ; Qi L; Gao JF; Zang YJ
    Zhonghua Nan Ke Xue; 2022 Mar; 28(3):211-216. PubMed ID: 37462958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.